What safety measures must be in place to work with retroviral DNAs and retroviruses at Duke?
From the Duke Occupational & Environmental Safety Office (OESO) “Experiments involving the utilization of recombinant DNA may require approval by the Duke University Institutional Biosafety Committee (IBC) prior to submission to outside agencies and the initiation of experimentation. PIs should obtain proper Recombinant DNA forms. All research involving viral vector expression systems (including retrovirus) must be registered by completing and submitting the Duke Viral Vector Registration form. An IBC representative will confirm that the appropriate handling precautions have been prescribed after reviewing the information included in the form. The RNAi Facility is required to reports the distribution of retroviral vector DNAs to the Duke Biosafety Office, so please ensure the proper SOPs and approvals are in place for your studies. Return to top.
